Dipti Patel-Donnelly, M.D.

VCS Physicians

Dipti Patel-Donnelly, M.D. Headshot

Our understanding of the mechanisms and driving mutations of cancer are rapidly evolving. We use our medical knowledge, judgement, and vast experience to offer the most personalized, comprehensive, and compassionate care to guide every person through this challenging journey together.

Primary Location:

Fairfax Office
Position

Medical Oncologist

Board Certification

Medical Oncology, Hematology and Internal Medicine

Fellowship

Dana-Farber Cancer Institute/Partners Cancer Care, Medical Oncology and Hematology

Internship

Mount Sinai School of Medicine

Residency

Mount Sinai School of Medicine

Medical School

Mount Sinai School of Medicine

College

Binghamton University

Dr. Patel-Donnelly is triple board-certified in medical oncology, hematology, and internal medicine. She completed her fellowship in Medical Oncology and Hematology at the Dana-Farber Cancer Institute/Brigham and Women’s Hospital/Massachusetts General Hospital at Harvard Medical School. Dr. Patel-Donnelly received her Doctorate of Medicine and completed her Internal Medicine Internship and Residency from the Mount Sinai School of Medicine in New York, New York, and she is a magna cum laude graduate in biochemistry with honors and independent research from Binghamton University in Binghamton, New York.

Dr. Patel-Donnelly has taken an active role at Virginia Cancer Specialists and in the local and medical communities. Dr. Patel-Donnelly holds memberships and appointments in multiple organizations. She is a member of the American Medical Association, the American Society of Clinical Oncology, the American Society of Hematology, and the Medical Society of Virginia. Focusing on a special interest in hematologic malignancies, brain tumors, and stem cell transplant, Dr. Patel-Donnelly has become highly involved in local tumor boards and has served as Section Chief of Hematology/Oncology at Inova Fairfax Hospital and has held a Hematology/Oncology Faculty Clerkship appointment at Virginia Commonwealth University. Dr. Patel-Donnelly has also received multiple awards and honors which include the Harvard Partners in Excellence Award, Leukemia and Lymphoma Society’s “Relentless for a Cure” award, Excellence in Teaching Awards, National Institutes of Health Research Fellowship, NASE Achievement Scholarship, and Distinguished Honors and Independent Research in Biochemistry. Dr. Patel-Donnelly has been consistently named as a Top Doctor in publications such as Northern Virginia Magazine and Washingtonian magazine. Additionally, she has been listed as a “Castle Connolly Mid-Atlantic Top Doctor and a Washington Post Super Doctor”. Dr. Patel-Donnelly is a published author and has spoken both at local educational events and at national and local news interviews.

Dr. Patel-Donnelly is a member of several, prestigious, national committees. She is on the highly-selective, national panel tasked with writing Oncology Board questions for the American Board of Internal Medicine, which certifies that medical oncologists have a competent fund of knowledge to be board-certified and practice. She has also been selected to serve on the American Society of Clinical Oncology (ASCO) Leukemia Guideline Committee, which reviews current research evidence and makes uniform guidelines on treating leukemia. Dr. Patel-Donnelly is currently an Assistant Professor, in the Department of Oncology at Johns Hopkins University.

Dr. Patel-Donnelly lives in Northern Virginia with her husband and two children. She enjoys spending time with her family, cooking, running, traveling, and reading.


 

Practice Blog

October 16, 2018

The Multiple Myeloma Research Foundation (MMRF) Patient Weekend Photo Albums and a Special Thanks

Read More
September 30, 2018

Join Virginia Cancer Specialists for a Weekend of Learning and Engaging MMRF PATIENT WEEKEND Washington D.C.

Read More

Physician Publications

December 28, 2017

Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL

Read More
April 1, 2017

WALDENSTRÖM'S MACROGLOBULINEMIA MASQUERADING AS BIRDSHOT CHORIORETINOPATHY.

Read More
January 16, 2014

Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy

Read More

More Publications by Dipti Patel-Donnelly, M.D.

June 2, 2013

Results of a phase I/II study (NCT01365559) of carfilzomib (CFZ) replacing bortezomib (BTZ) in BTZ-containing regimens for BTZ-treated patients (pts) with relapsed and refractory multiple myeloma (MM).

Read More
November 15, 2012

Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma.

Read More
December 11, 2011

Bendamustine Combined with Bortezomib Has Efficacy in Patients with Relapsed or Refractory Multiple Myeloma: A Phase 1/2 Study

Read More
October 20, 2009

Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphoma.

Read More
January 1, 2003

The dynamics of GPIIb/IIIa-mediated platelet-platelet interactions in platelet adhesion/thrombus formation on collagen in vitro as revealed by videomicroscopy

Read More

Primary Location

Fairfax Office Office

Fairfax Office

Learn More

Other Locations

Awards

January 1, 2018
Northern Virginia Magazine Top Doctors 2018

Northern Virginia Magazine Top Doctors 2018


November 1, 2017
Washingtonian Magazne Top Doctors 2017

Washingtonian Magazne Top Doctors 2017


September 9, 2016
Washingtonian Magazine

Washingtonian Top Doctor 2016


December 31, 2013
Washingtonian Magazine

Top Doctor 2014


January 31, 2013
Northern Virginia Magazine

Top Doctor 2013